{"entity":{"type":"insider","cik":"0001907345","url":"/insider/0001907345","json_url":"/insider/0001907345.json","name":"Lee Gary K.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":7,"first":"2025-08-13","last":"2026-08-11","span_basis":"filed_date"},"name_variants":[{"name":"Lee Gary K.","source":"filing","n_filings":7,"first_seen":"2025-08-13","last_seen":"2026-08-11"}],"transactions":[{"id":9296702,"accession":"0001907345-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001907345-26-000004","line_url":"/filing/0001907345-26-000004#line-1","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0001907345","owner_name":"Lee Gary K.","owner_display_name":"Lee Gary K.","owner_url":"/insider/0001907345","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":131.0,"shares_display":"131","price_per_share":14.34,"price_display":"14.34","price_state":"stated","total_value":1878.54,"total_display":"1,878.54","total_whole":"1,879","shares_owned_after":17677.0,"shares_owned_after_display":"17,677","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-11","scope":"insider"},{"id":5877304,"accession":"0001907345-26-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001907345-26-000003","line_url":"/filing/0001907345-26-000003#line-1","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0001907345","owner_name":"Lee Gary K.","owner_display_name":"Lee Gary K.","owner_url":"/insider/0001907345","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":130.0,"shares_display":"130","price_per_share":18.92,"price_display":"18.92","price_state":"stated","total_value":2459.6,"total_display":"2,459.60","total_whole":"2,460","shares_owned_after":17808.0,"shares_owned_after_display":"17,808","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-11","filed_date":"2026-06-15","scope":"insider"},{"id":6066329,"accession":"0001907345-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001907345-26-000002","line_url":"/filing/0001907345-26-000002#line-1","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0001907345","owner_name":"Lee Gary K.","owner_display_name":"Lee Gary K.","owner_url":"/insider/0001907345","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1671.0,"shares_display":"1,671","price_per_share":23.39,"price_display":"23.39","price_state":"stated","total_value":39084.69,"total_display":"39,084.69","total_whole":"39,085","shares_owned_after":16938.0,"shares_owned_after_display":"16,938","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-11","filed_date":"2026-02-12","scope":"insider"},{"id":6066326,"accession":"0001907345-26-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001907345-26-000001","line_url":"/filing/0001907345-26-000001#line-2","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0001907345","owner_name":"Lee Gary K.","owner_display_name":"Lee Gary K.","owner_url":"/insider/0001907345","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":147.0,"shares_display":"147","price_per_share":23.12,"price_display":"23.12","price_state":"stated","total_value":3398.64,"total_display":"3,398.64","total_whole":"3,399","shares_owned_after":18609.0,"shares_owned_after_display":"18,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-10","filed_date":"2026-02-11","scope":"insider"},{"id":5062449,"accession":"0001907345-25-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001907345-25-000006","line_url":"/filing/0001907345-25-000006#line-1","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0001907345","owner_name":"Lee Gary K.","owner_display_name":"Lee Gary K.","owner_url":"/insider/0001907345","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":138.0,"shares_display":"138","price_per_share":16.16,"price_display":"16.16","price_state":"stated","total_value":2230.08,"total_display":"2,230.08","total_whole":"2,230","shares_owned_after":15366.0,"shares_owned_after_display":"15,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-10","filed_date":"2025-11-12","scope":"insider"},{"id":4036704,"accession":"0001415889-25-022740","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-022740","line_url":"/filing/0001415889-25-022740#line-2","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0001907345","owner_name":"Lee Gary K.","owner_display_name":"Lee Gary K.","owner_url":"/insider/0001907345","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1453.0,"shares_display":"1,453","price_per_share":10.544,"price_display":"10.54","price_state":"stated","total_value":15320.432,"total_display":"15,320.43","total_whole":"15,320","shares_owned_after":15504.0,"shares_owned_after_display":"15,504","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-21","filed_date":"2025-08-22","scope":"insider"},{"id":4109808,"accession":"0001415889-25-021692","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-021692","line_url":"/filing/0001415889-25-021692#line-2","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0001907345","owner_name":"Lee Gary K.","owner_display_name":"Lee Gary K.","owner_url":"/insider/0001907345","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":136.0,"shares_display":"136","price_per_share":10.338,"price_display":"10.34","price_state":"stated","total_value":1405.968,"total_display":"1,405.97","total_whole":"1,406","shares_owned_after":8957.0,"shares_owned_after_display":"8,957","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-13","scope":"insider"},{"id":4109803,"accession":"0001415889-25-021692","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-021692","line_url":"/filing/0001415889-25-021692#line-1","is_derivative":false,"issuer_cik":"0001806952","issuer_name":"Lyell Immunopharma, Inc.","issuer_ticker":"LYEL","issuer_name_source":null,"issuer_url":"/issuer/0001806952","owner_cik":"0001907345","owner_name":"Lee Gary K.","owner_display_name":"Lee Gary K.","owner_url":"/insider/0001907345","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":131.0,"shares_display":"131","price_per_share":10.526,"price_display":"10.53","price_state":"stated","total_value":1378.906,"total_display":"1,378.91","total_whole":"1,379","shares_owned_after":9093.0,"shares_owned_after_display":"9,093","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-11","filed_date":"2025-08-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001806952","name":"Lyell Immunopharma, Inc.","url":"/issuer/0001806952","role":"Officer (Chief Scientific Officer)","n_filings":7,"first_seen":"2025-08-13","last_seen":"2026-08-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001907345","retrieved_at":"2026-08-23T00:28:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}